Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Silverberg

Showing results (371-380 of 670) with videos related to

Pageof 67
Sort By:
The Journal of Dermatological Treatment|September 11, 2023
Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis RegistryJonathan I Silverberg, Evangeline Pierce, Meghan Feely, et al.
International Journal of Medical Sciences|July 9, 2009
Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case reportMartin H Bluth, Stephan Kohlhoff, Kevin B Norowitz, et al.
Journal of the American Academy of Dermatology|October 16, 2016
Ten-year mortality is increased after hospitalization for atopic dermatitis compared with the general population, but reduced compared with psoriasisAlexander Egeberg, Lone Skov, Yuki M F Andersen, et al.
Journal of the American Academy of Dermatology|August 16, 2019
Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination SurveyYevgeniy R Semenov, Christina M Herbosa, Andrew T Rogers, et al.
Frontiers in Pediatrics|September 25, 2024
Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 yearsAmy S Paller, Jonathan I Silverberg, Mercedes E Gonzalez, et al.
JAMA Dermatology|May 26, 2021
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin DiseasesMaria C Schneeweiss, Seoyoung C Kim, Richard Wyss, et al.
Dermatology and Therapy|November 4, 2023
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative ReviewAndrew Blauvelt, Richard G Langley, Kenneth B Gordon, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 7, 2021
Effects of dupilumab treatment on patch test reactions: A retrospective evaluationLinde E M de Wijs, José D van der Waa, Tamar Nijsten, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|September 27, 2023
Assessment and Management of Sleep Disturbances in Atopic Dermatitis: A ReviewArchana Samynathan, Anna B Fishbein, Sabra M Abbott, et al.
American Journal of Clinical Dermatology|April 7, 2021
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical TrialsBrett King, Catherine Maari, Edward Lain, et al.
Pageof 67

Showing results (371-380 of 670) with videos related to

Sort By:
Pageof 67
The Journal of Dermatological Treatment|September 11, 2023
Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis RegistryJonathan I Silverberg, Evangeline Pierce, Meghan Feely, et al.
International Journal of Medical Sciences|July 9, 2009
Immune responses in autoimmune hepatitis: effect of prednisone and azathioprine treatment: case reportMartin H Bluth, Stephan Kohlhoff, Kevin B Norowitz, et al.
Journal of the American Academy of Dermatology|October 16, 2016
Ten-year mortality is increased after hospitalization for atopic dermatitis compared with the general population, but reduced compared with psoriasisAlexander Egeberg, Lone Skov, Yuki M F Andersen, et al.
Journal of the American Academy of Dermatology|August 16, 2019
Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination SurveyYevgeniy R Semenov, Christina M Herbosa, Andrew T Rogers, et al.
Frontiers in Pediatrics|September 25, 2024
Dupilumab treatment reduces caregiver-reported skin pain in patients with moderate-to-severe atopic dermatitis aged 6 months to 5 yearsAmy S Paller, Jonathan I Silverberg, Mercedes E Gonzalez, et al.
JAMA Dermatology|May 26, 2021
Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin DiseasesMaria C Schneeweiss, Seoyoung C Kim, Richard Wyss, et al.
Dermatology and Therapy|November 4, 2023
Next Generation PDE4 Inhibitors that Selectively Target PDE4B/D Subtypes: A Narrative ReviewAndrew Blauvelt, Richard G Langley, Kenneth B Gordon, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 7, 2021
Effects of dupilumab treatment on patch test reactions: A retrospective evaluationLinde E M de Wijs, José D van der Waa, Tamar Nijsten, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|September 27, 2023
Assessment and Management of Sleep Disturbances in Atopic Dermatitis: A ReviewArchana Samynathan, Anna B Fishbein, Sabra M Abbott, et al.
American Journal of Clinical Dermatology|April 7, 2021
Extended Safety Analysis of Baricitinib 2 mg in Adult Patients with Atopic Dermatitis: An Integrated Analysis from Eight Randomized Clinical TrialsBrett King, Catherine Maari, Edward Lain, et al.
Pageof 67